Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Journal of Neuroimmunology|March 17, 2004
The extent of cytokine induction in peripheral nerve lesions depends on the mode of injury and NMDA receptor signalingC Kleinschnitz, J Brinkhoff, M Zelenka, et al.Der Nervenarzt|June 7, 2007
[Update on pathophysiologic and immunotherapeutic approaches for the treatment of multiple sclerosis]C Kleinschnitz, S G Meuth, B C Kieseier, et al.Der Nervenarzt|November 18, 2008
[Multiple sclerosis -- a channelopathy? Targeting ion channels and transporters in inflammatory neurodegeneration]S G Meuth, N Melzer, C Kleinschnitz, et al.Der Nervenarzt|June 8, 2011
[Pregabalin and gabapentin in multiple sclerosis: clinical experiences and therapeutic implications]S Bittner, K Höhn, K Göbel, et al.Der Nervenarzt|November 12, 2015
["Time is brain" in relapsing remitting multiple sclerosis. Current treatment concepts in immunotherapy]R Linker, B-A Kallmann, C Kleinschnitz, et al.Mediators of Inflammation|August 24, 2017
Intrathecal Resiniferatoxin Modulates TRPV1 in DRG Neurons and Reduces TNF-Induced Pain-Related BehaviorM Leo, M Schulte, L-I Schmitt, et al.Hamostaseologie|May 20, 2015
Platelets and vascular inflammation of the brainM Mezger, K Göbel, P Kraft, et al.Seminars in Immunopathology|June 5, 2023
Thromboinflammatory challenges in stroke pathophysiologyR D Szepanowski, S Haupeltshofer, S E Vonhof, et al.Journal of Thrombosis and Haemostasis : JTH|September 15, 2012
Redundant functions of phospholipases D1 and D2 in platelet α-granule releaseI Thielmann, D Stegner, P Kraft, et al.Tissue Antigens|June 12, 2004
Analysis of the monocyte chemoattractant protein 1 -2518 promoter polymorphism in patients with multiple sclerosisA Kroner, M Mäurer, S Loserth, et al.Pageof 4